GF Fund Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7K Buy
1,175
+95
+9% +$836 ﹤0.01% 534
2026
Q2
$8.76K Sell
1,080
-42
-4% -$308 ﹤0.01% 547
2026
Q1
$7.17K Buy
1,122
+133
+13% +$858 ﹤0.01% 586
2025
Q4
$5.88K Buy
+989
New +$5.25K ﹤0.01% 616

Other funds holding PBYI

GF Fund Management's PBYI Position: Q3 2026 in Review

GF Fund Management increased its Puma Biotechnology (PBYI) stake by 8.8% in Q3 2026, buying an estimated $836 and bringing the position to 1,175 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

GF Fund Management first reported a position in PBYI in Q4 2025 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • GF Fund Management held 1,175 shares of Puma Biotechnology worth $11.7K as of Q3 2026.
  • GF Fund Management bought 95 Puma Biotechnology shares in Q3 2026, an estimated $836.
  • Puma Biotechnology made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #534 holding.
  • GF Fund Management first reported a position in Puma Biotechnology in Q4 2025 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.